相关实验视频
Updated: Jan 16, 2026

08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.9K
儿科哈普洛同一性造血干细胞移植的成本评估
Leila Achour1,2, Ikram Fazaa1,2, Chema Drira1,2
1Pharmacy Department, National Bone Morrow Transplant Center, Tunis, Tunisia.
ClinicoEconomics and outcomes research : CEOR
|October 6, 2025
概括
儿科哈普洛-SCT比基因-SCT更昂贵,儿科患者的总体开支更高. 这项研究为突尼斯的造血干细胞移植 (HSCT) 提供了量身定制的补偿.
科学领域:
- 药物经济学 药物经济学
- 血液学 血液学 血液学
- 卫生政策 卫生政策
背景情况:
- 造血干细胞移植 (HSCT) 是各种儿科和成人疾病的关键治疗方法.
- 对成本效益的分析对于制定可持续的医疗保健报销策略至关重要.
研究的目的:
- 在CNGMO评估儿科哈普洛-SCT和成人/儿科基因-SCT的成本.
- 通知突尼斯医疗保险基金提供量身定制的退款套餐.
主要方法:
- 使用基于活动的成本计算的药物经济研究.
- 从医院的角度评估成本,包括直接的医疗和非医疗成本.
主要成果:
- 儿科患者的费用比成人患者的费用更高.
- 对儿科患者来说,哈普洛-SCT比基因-SCT更昂贵.
- 密集的调节方案,更长的住院时间和并发症 (感染,GVHD,CMV重新激活) 会导致更高的成本.
结论:
- 制定了针对儿科患者的哈普洛-SCT和基因-SCT新的,具体的补偿计划的标准.
- 提供一个公平和可持续的HSCT资金的基础.
相关概念视频
Bone Marrow Sampling and Transplants
881
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
881
Hematopoiesis
8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K

